A cannabis extract business
A cannabis extract over 0.2% THC is a Category 5 narcotic in Thailand. For medicine, the applicant must be a Thai entity with a drug or herbal-product factory licence.
When the extract is a narcotic
The Category 5 line is the 2022 notification, not the 2026 regulation. Every extract is Category 5 except a permitted extract of not more than 0.2% THC by weight from plants grown in Thailand, and an extract of seed from plants grown in Thailand. [1]
Once 30 days after 26 March 2026 have elapsed, the narcotic extract may be produced, imported, exported, sold, or possessed only for government narcotics work, medicine, analysis or medical or scientific research, or industry. For medical production the applicant must be a Thai juristic person that is not foreign under the Foreign Business Act, or a government agency, or the Thai Red Cross, and must hold a modern-drug or herbal-product manufacturing licence. Import and export for medicine or industry use the same Thai-entity test. The seller must already be the licensed producer or importer. [2]
Every batch is assayed for THC. The result stays at the licensed premises for at least three years. The label says, in red Thai, that the contents are a Category 5 narcotic, and that they are a raw material only. [2]
Extract licence fees
Fees: 10,000 baht to produce or import, 5,000 to export, 2,000 to sell or possess, 500 for a one-time import or export, and half on renewal. The Thai Red Cross, government agencies, and state juristic persons that are not state enterprises do not pay. Licences issued under the repealed B.E. 2563 hemp regulation and the B.E. 2564 cannabis regulation remain valid until 31 December 2026. [2]
A company with 50% or more foreign shareholding needs a foreign-business licence to grow the crop, and those licences are not granted as a matter of course. The extract regulation is stricter than that general rule: the licensee itself must not be a foreigner under the Foreign Business Act. A minority foreign shareholder can still fit. A foreign-controlled company cannot hold the high-THC extract licence. [2]